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Endogenous IL-21 regulates pathogenic mucosal
CD4 T-cell responses during enhanced RSV
disease in mice
JS Dodd1, D Clark1,2, R Muir1, C Korpis1 and PJM Openshaw1
A role for interleukin-21 (IL-21) has recentlybeen found in several diseases, but contribution tomucosal defenceshasnot
been described. In BALB/c mice infected with respiratory syncytial virus (RSV), IL-21 depletion had little effect in
primary infection. However, depletion of mice during priming with recombinant vaccinia expressing RSV G protein
(which primesRSV-specific T helper type 2 cells and causes lung eosinophilia during RSV infection) further exacerbated
pathology during RSV challenge, with reduced viral clearance and impaired virus-specific serum antibody responses.
This enhancement was accompanied by lymphocyte, neutrophil, and antigen-presenting cell recruitment to the
lungs, with increased bronchoalveolar lavage interferon-c and IL-17 levels. Adoptive transfer of splenic CD4 Tcells from
depleted mice into naive recipients replicated these effects, indicating that IL-21 mediates its effects via CD4 T cells.
Endogenous IL-21, therefore, has potent and specific effects on mucosal antiviral responses, assisting viral clearance,
regulating pulmonary T- and B-cell responses, and inhibiting IL-17 production.
INTRODUCTION
Respiratory syncytial virus (RSV) is a major cause of viral
bronchiolitis in infants,1 also causing seasonal exacerbations
and deaths due to respiratory disease in elderly persons.2 The
immune response to RSV infection is complex, involving
innate, humoral, and cellular immune responses; all have a role
in both antiviral protection and disease pathogenesis.3 RSV
vaccine development has been hampered by the failure of a
formalin-inactivated RSV vaccine in the 1960s, which led to
disease exacerbation after subsequent natural viral infection
associated with excessive lung inflammation. Several hypoth-
eses have been advanced to explain disease exacerbation,
including vaccine-triggered T helper type 2 (Th2)-biased CD4
T-cell responses caused by carbonylation4 and low-avidity
poorly neutralizing antibodies that form immune complexes in
the lungs.5 In addition, IL-17 production by CD4 T cells has
recently been implicated in enhanced disease.6,7
Interleukin (IL)-21 is a regulatory cytokine produced by
activated CD4 T cells8 natural killer (NK) T cells,9 T follicular
helper cells10 and Th17 cells.11 Although IL-21 production is
restricted to a few cell types, its receptor (IL-21R), is expressed
on CD4 and CD8T cells, B cells, NK cells, NKT cells, gdT cells,
dendritic cells (DCs), macrophages, keratinocytes, and fibro-
blasts.12,13 IL-21 has been reported to control the differentiation
and functional activity of T cells,8 B cells,14 and NK cells,15 to
limit the differentiation of regulatory T cells,16 and promote T
cells resistance to regulatory-T-cell-mediated immune sup-
pression.17 It also stimulates epithelial cells and fibroblasts to
produce inflammatory mediators.13,18
Our understanding of the role of IL-21 in T-cell differentia-
tion is evolving rapidly. The differentiation of naive T cells into
Th2 cells may be enhanced by IL-21,19 while under other
conditions it may drive T cells and NK cells towards interferon
(IFN)-g production20 and promote Th17 differentiation.21,22
IL-21, like IL-10, is produced by all pro-inflammatory T-cell
lineages, indicating that it may have crucial anti-inflammatory
functions by regulating T-cell activation. For example, IL-21
has been shown to inhibit immediate hypersensitivity reactions
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in the skin,23 and CD8 T-cell responses to tumors.24 It boosts IL-
10 production in visceral leishmaniasis25 by human naive CD4 T
cells,26 Tr1 cells,27 and NK cells.28 A lack of IL-21 may lead to
dysregulated responses against hepatitis B virus in the young29
and boost IL-17 production by CD4 T cells in Listeria
monocytogenes infection.30 Increased IL-21 expression by
CD4 T cells was associated with control of HIV replication,
but thismay simply reflect greaterT-cell activity.31,32 Its increased
production has also been positively correlated in several diseases,
but this again may reflect self-regulation by activated T cells.33,34
Although the role of IL-21 has been studied inmany diseases,
there is little known about its role in respiratory infections. In
this study, we have used a well-characterized mouse model of
immunization-enhanced RSV bronchiolitis to investigate the
role of IL-21 on CD4 T-cell responses to RSV infection. We
found that IL-21 depletion at immunization compromised viral
clearance, significantly inhibited production of virus-specific
serum antibody levels, and caused pronounced dysregulation of
the CD4 T-cell response.
RESULTS
IL-21 depletion increases CD4 T-cell responses to primary
RSV challenge
We determined the effect of IL-21 depletion on responses to
primary RSV infection in naive mice. Disease (measured by
weight loss) is negligible until d5–7 post challenge (PC) and
peaks at d6–7 PC. Although weight loss increased with IL-21
depletion, the change was not significant (Figure 1a). In
primary infection, RSV replication is detectable at d2 PC, peaks
at d4 PC, and returns to baseline by d7 PC. IL-21 depletion did
not alter this kinetic, but there was a significant decrease in L
gene expression levels in depleted mice on d4 PC (Figure 1b).
Next, we measured T-cell and NK cell recruitment into the
airways. CD8 T-cell and NK cell recruitment or activation were
unaffected by depletion, but there was a significant increase in
CD4T-cell recruitment at d7 PC (Figure 1c), especially of ICOS
(inducible costimulatory molecule)-expressing CD4 cells
(Figure 1d). We then tested the effect of IL-21 depletion
on bronchoalveolar lavage (BAL) cytokines and chemokines,
markers of immune activation in the lung. We could not detect
IL-21 (data not shown), and IL-4 and tumor necrosis factor
levels were not affected by IL-21 depletion. By contrast, the pro-
inflammatory mediators IFN-g and RANTES (regulated and
normal T cell expressed and secreted) both increased in
depleted mice (Figure 1e). We observed a threefold increase in
the proportion of CD4 T cells producing IFN-g in IL-21-
depleted mice (Figure 1f). Thus, endogenous IL-21 tends to
restrain inflammation and antiviral defense, but the effects are
mild in primary RSV infection and are mediated primarily via
CD4 T cells.
IL-21 depletion during priming exacerbates
immunopathology after RSV challenge
In order to enhance the dependency of inflammation on the
CD4 T-cell response and to explore the effects of IL-21 in more
detail, we opted to study the effects of IL-21 on RSV disease
augmented by previous senitization via cutaneous immunization
with recombinant vaccinia virus expressing RSV surface
glycoprotein G (rVV-G). This prime-challenge regimen induces
a strong CD4 T-cell-mediated, Th2-driven immunopathology
that causes lung eosinophilia after RSV challenge35 and parallels
some of the clinical and immunological features observed in
infantile RSV bronchiolitis. Depletion had no effect on vaccinia
lesions or on resolution of cutaneous infection (data not
depicted), and our analysis, therefore, focussed on the effects
of IL-21 depletion on the pulmonary response to RSV challenge.
rVV-G sensitized mice lost weight immediately after RSV
challenge, peaking atB15% on d4 PC, with recovery by d7 PC
(Figure 2a). IL-21 depletion significantly increased the
magnitude of weight loss, peaking at B25% on d5–6 PC.
Moreover, the kinetic of recovery was delayed with no mouse
recovering fully by d8 PC. In some experiments, weight loss was
followed to d14 PC but still showed incomplete recovery (data
not depicted).
Weight loss correlates with recruitment of activated cells to
the lung and airway; therefore, we studied cell recruitment by
flow cytometry, observing that both total BAL and lung cell
counts were significantly increased in IL-21-depleted mice on
d5 PC. Specifically, we observed significant increases in
recruitment of CD4 T cells, CD8 T cells, and NK cells to
the BAL (Figure 2c). Activity of recruited T cells (as measured
by ICOS and CD69 expression) was also greater in depleted
mice (data not shown). By contrast, we observed a significant
reduction in B cells in IL-21-depleted mice (Figure 2c). IL-21
depletion also boosted granulocytosis: we observed a significant
increase in neutrophil (CD3 /B220 /CD11bþ /CCR3 )
recruitment but not eosinophilia (CD3 /B220 /CD11bþ /
CCR3þ ; Figure 2d). Recruitment of DCs was also observed to
increase in depleted mice using three separate markers: MHCII
(major histocompatibility complex II), CD11b, and CD11c
(Figure 2e). Similar changes were also observed in recruitment
to the lung tissue (data not shown). We also measured IFN-g,
IL-4, IL-10, and IL-17 levels in the BAL fluid of mice on d5 PC
and found that there were significant increases in IFN-g, IL-10,
and IL-17, and a significant decrease in IL-4, in IL-21-depleted
mice (Figure 2f). IL-21was barely detectable (o35 pgml 1) in
BAL fluid (data not shown).
Next we checked whether viral clearance was affected. Mice
primed with rVV-bgal, which develop no anti-RSV memory,
exhibited significant viral replication at d4 PC. Immunization
reduced viral replication to undetectable levels; however, viral
genome was detectable in IL-21-depleted mice, suggesting
clearance had been compromised (Figure 2b). IL-21 depletion
did not alter the kinetics of replication, and by d7 PC, all mice
had cleared the virus.
IL-21 depletion reduces antibody production in primed,
RSV-challenged mice
As viral-specific antibody is a crucial component of long-term
protective anti-viral immunity, we determined the effect of
IL-21 depletion on serum RSV-specific antibody levels.
Priming with RSV G protein results in weak but detectable
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levels of RSV-specific immunoglobulin G1 (IgG1) and IgG2a
(Figure 3a). No virus-specific IgA or IgE was detected (data not
shown). IL-21 depletion reduced RSV-specific IgG1 levels but
not IgG2a (Figure 3a). We then measured serum RSV-specific
antibody 14 d post RSV challenge when the virus has been
cleared and cellular response reduced to baseline levels. There
were enhanced RSV-specific IgG1 and IgG2a levels in control
mice compared with pre-RSV challenge, and IL-21 depletion
significantly reduced levels of both antibody isotypes
(Figure 3b).
IL-21 depletion at priming boosts the number of activated
lung CD4 T cells after RSV challenge
To examine how IL-21 depletion affects CD4 T-cell differ-
entiation, we determined FoxP3, RORgt (related orphan
receptor-gt), and T-bet expression in splenic CD4 T cells
before RSV challenge and lung CD4 T cells at d5 PC (peak of
disease severity). IL-21 depletion did not alter FoxP3
(Figure 4a), RORgt (Figure 4b), or T-bet (Figure 4c)
expression by splenic CD4 T cells (Figure 4d) nor did it
alter cell numbers (Figure 4e).However, at d5PC, a significantly
reduced proportion of BAL CD4 T cells from IL-21-depleted
mice expressed FoxP3 (Figure 5a,d), while the proportion
expressing RORgt (Figure 5b,d) or T-bet (Figure 5c,d) was
similar. Consequently, there was an increase in total RORgtþ
and T-betþ BAL CD4 T-cell numbers as a result of IL-21
depletion (Figure 5e). This trend also occurred in lung tissue
(see Supplementary Figure S1 online), but there were no
significant differences in the cells of the mediastinal lymph
nodes (see Supplementary Figure S2 online).
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Figure 1 Interleukin-21 (IL-21) depletion increases CD4 T-cell responses to primary respiratory syncytial virus (RSV) challenge. Mice were challenged
with RSV on d0 and treated with aIL-21 antibody (0.5mg; intraperitoneally; Dep) or isotype control (Con) 1 day before and after challenge. (a) Mice
were weighed daily, and percentage of weight loss was calculated. Lungs were harvested, processed, and RNA extracted as described in Materials and
Methods. cDNA was produced by real-time reverse transcriptase–PCR and copies of the RSV L gene were determined by quantitative PCR
(Taqman). Plasmids encoding the L genewere used as standards to quantitate L gene copies. (b) Results are expressed as the number of L gene copies.
Bronchoalveolar lavage (BAL) fluid and lungs were harvested at d7 post challenge. CD4 T cell, CD8 T cell, and natural killer (NK) cell recruitment into
(c) BAL fluid and (d) their ICOS (inducible costimulatory molecule) expression was determined by flow cytometry. (e) Cytokines were quantitated
in BAL fluid by sandwich enzyme-linked immunosorbent assay. (f) Interferon (IFN)-g production by lung CD4 and CD8 T cells was determined by flow
cytometry. Error bars represent s.e.m. The graphs are representative of three independent experiments of five mice per group. Student’s t-test result;
*Po0.05, **Po0.01, ***Po0.001. RANTES, regulated and normal T cell expressed and secreted; TNF, tumor necrosis factor.
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Lung CD4 T cells from rVV-G primed, IL-21-depleted mice
secrete more IFN-c and IL-17 after RSV challenge
As IL-21 depletion increased total numbers of RORgtþ and
T-betþ CD4T cells in BAL and lung, wewanted to confirm that
lung CD4 T cells were producing increased levels of IL-17 and
IFN-g. Therefore, 5 d PC, we stimulated lung cells with either
media or aCD3/28 beads overnight and stained them for
cytokine production the next day. There were increased
percentages of CD4 T cells in IL-21-depleted mice
(Figure 6a). Approximately 12% of these cells from both
the groups of mice produced IFN-g (but no IL-17) after
stimulation with media alone (Figure 6b). Production of both
IFN-g and IL-17 increased when the cells were stimulated with
aCD3/28 beads o/n (Figure 6c). However, lung CD4 T cells
from IL-21-depleted mice produced significantly more IFN-g
and IL-17 (both single and co-producing populations) than
control cells (Figure 6d). We also determined whether there
was increased production post priming in the spleen (see
Supplementary Figure S3 online). There was no change in
IFN-g production; however, there was a small but significant
increase in IL-17 production in the depleted group (see
Supplementary Figure S3c,d online).
IL-21 depletion enhances cytokine production by lung CD4
T cells
To determine the effect of IL-21 depletion on cytokine
production by antigen-specific CD4 T cells, we sorted CD4
T cells and DCs from the lungs of rVV-G primed, control, and
IL-21-depleted mice at the peak of disease (d5 PC) after RSV
challenge. The DCs were pulsed with specific G peptide (p31;
G184-198) or control peptide (p11; G64-78) and co-cultured
with CD4 T cells. Cytokine levels in the supernatant were
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Figure 2 Interleukin-21 (IL-21) depletion exacerbates immunopathology but compromises viral clearance upon respiratory syncytial virus (RSV)
challenge. Mice were immunized with vaccinia virus expressing bgal (Non-vaccinated) or RSV G protein (rVV-G) and treated with aIL-21
antibody (0.5mg; intraperitoneally; Dep) or isotype control (Con) 1 day before and 2 days after immunization. They were challenged with RSV 14 days
later. (a) Mice were weighed daily, and percentage of weight loss was calculated. Lungs were harvested, processed, and RNA extracted as described in
Materials and Methods. cDNA was produced by real-time reverse transcriptase–PCR and copies of the RSV L gene were determined by quantitative
PCR (Taqman). Plasmids encoding the L gene were used as standards to quantitate L gene copies. (b) Results are expressed as the number of L gene
copies. Bronchoalveolar lavage (BAL) fluid and lungs were harvested at d5 post challenge. (c) CD4 T cell, CD8 T cell, B cell and NK cell recruitment, (d)
granulocyte recruitment, and (e) antigen presenting cell recruitment into BAL fluid was determined by flow cytometry. Cytokines were quantitated in BAL
fluid by sandwich enzyme-linked immunosorbent assay (f). Error bars represent s.e.m. The graphs are representative of three independent experiments
of fivemice per group. Analysis of variance (Tukey’s post-test) or Student’s t-test result; *Po0.05, **Po0.01, ***Po0.001. APC, antigen-presenting cell;
IFN, interferon; NK, natural killer.
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determined after 72 h by enzyme-linked immunosorbent assay
(ELISA). DCs from either group pulsed with control peptide
did not elicit cytokine production by CD4 T cells (Figure 7).
DCs from control mice pulsed with RSV G peptide elicited
IFN-g (Figure 7a) and IL-21 (Figure 7c) by CD4 T cells. There
was also a small but detectable IL-4 (Figure 7d), IL-10
(Figure 7b), and IL-17 (Figure 7e) response. By contrast, CD4
T cells from IL-21-depleted mice produced significantly more
IFN-g, IL-4, IL-10, and IL-17 upon stimulation with specific
antigen. However, IL-21 was not produced by these cells,
suggesting that IL-21 depletion during priming had abolished
the capacity of T cells to produce IL-21 (Figure 7c).
Adoptive transfer of CD4 T cells from rVV-G primed,
IL-21-depleted, RSV-infected mice exacerbates
immunopathology in recipient mice after RSV challenge
As there is no direct method by which to isolate anti-RSV-G-
protein-specific memory CD4 T cells, we determined the
cytokine secretion profile of G-specific cells taken 28 d post
RSV challenge, after stimulation with specific peptide (G184-
198). There was no cytokine production by naive spleen cells
after peptide stimulation (Figure 8). No IL-4 (Figure 8b), IL-17
(Figure 8d), or IL-21 (Figure 8f) production was detected from
G-specific spleen cells from control or IL-21-depleted mice;
therewasweak but detectable IL-10 production (Figure 8c), but
no significant difference resulting from IL-21 depletion. By
contrast, there was significant IFN-g (Figure 8a) and granzyme
B (Figure 8e) production by spleen cells, which was increased
by IL-21 depletion in vivo. The percentage of splenic CD4 T
cells expressing FoxP3 (Figure 9a), RORgt (Figure 9b), T-bet
(Figure 9c) did not differ significantly between the groups
(Figure 9d), but IL-21 depletion in vivo increased splenic CD4
T-cell numbers so that FoxP3þ , RORgtþ , and T-betþ CD4 T
cells increased in total number. Moreover, there were
significantly more FoxP3þ splenic CD4 T cells from
control mice compared with depleted mice (Figure 9e).
Splenic CD4 T cells from naive, control, or IL-21-depleted
primed and RSV challenged mice were MACS (magnetic
activation cell sorter)-sorted and adoptively transferred
(intraperitoneally (IP)) into naive recipient BALB/c mice
24 h before intranasal challenge with RSV. Lungs were
harvested on d7 (PC). Transfer of naive CD4 T cells did
not protect against disease, whereas CD4 T cells from primed,
non-depleted, mice significantly reduced weight loss. By
contrast, CD4 T cells from primed, IL-21-depleted mice
increased the magnitude of weight loss and did not protect
against the disease (Figure 10a). However, addition of
G-specific CD4 T cells did significantly reduce viral
replication compared with naive (see Supplementary
Figure S4 online). Increased weight loss was associated
with enhanced T-cell recruitment to the airway
(Figure 10d,e). Of the CD4 T cells recruited to the BAL
(Figure 10b) and lung (Figure 10c), most were T-betþ , and
there were significantly more when CD4 T cells from IL-21-
depleted mice were administered. There was also an increase in
FoxP3þ and RORgtþ BAL CD4 T cells in these mice.
Significantly more CD4 (Figure 10d) and recipient CD8
(Figure 10e) T cells expressed an activated phenotype (CD69þ ,
OX40þ , and ICOSþ ) when CD4 T cells were administered
from IL-21-depleted mice. CD4 T cells from IL-21-depleted
mice also recruited more BAL-recipient NK cells, though their
activity (as measured by CD69 expression) was identical
(Figure 10f). This increase in T-betþ CD4 T cells, CD8 T cells,
and NK cells increased BAL IFN-g (Figure 10g) but not IL-4
levels (Figure 10h). By contrast, there was no increase in BAL
IFN-g and a significant increase in IL-4 when control CD4 T
cells were administered. BAL IL-17 levels were unaltered
(Figure 10i).
To confirm whether these effects of IL-21 depletion were
restricted to CD4 T cells, we performed parallel experiments in
mice primed with RSV M2 protein (rVV-M2). Priming with
this protein elicits a CD8 T-cell memory that is recalled to the
pulmonary compartment upon RSV challenge. IL-21 depletion
had less significant effects on disease severity and no significant
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Figure 3 Interleukin-21 (IL-21) depletion decreases virus-specific
antibody production. Mice were immunized and challenged as described
in Figure 2. Sera from individual vaccinated mice were taken on
day 14 post priming, (a) before respiratory syncytial virus (RSV) challenge
or (b) 14 days post RSV challenge, and levels of RSV-specific
immunoglobulin G1 (IgG1) and IgG2a were determined by enzyme-linked
immunosorbent assay. The results shown are for 1:100 dilution and are
representative of two independent experiments of five mice per group.
Student’s t-test result; **Po0.01, ***Po0.001. OD, optical density.
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effect on CD8 T-cell influx into the airway or lung tissue.
Moreover, there were no significant changes in immune
responses between mice receiving CD8 T cells from control or
IL-21-depleted mice, confirming that the observed effects descri-
bed in this study are limited to CD4 T cells (data not shown).
DISCUSSION
Using IL-21 depletion, we found that endogenous IL-21 skews
CD4 T-cell activity: it inhibits recruitment of RORgtþ and
T-betþ CD4 T cells during RSV challenge and reduces IFN-g
and IL-17 production. Depletion also enhanced recruitment of
CD8 T cells, NK cells, and neutrophils during subsequent RSV
infection, indicating an enhanced inflammation with delayed
recovery.Many of these features could be transferred into naive
recipients by injection of splenic CD4 T cells from IL-21-
depleted mice, indicating direct involvement of T cells
programmed in the presence of IL-21 in these responses.
Although primarily anti-inflammatory, endogenous IL-21
seemed to promote clearance of RSV in vivo and enhance
virus-specific serum antibody production, suggesting that
IL-21 has therapeutic potential in boosting protective immunity
to viral infection, while inhibiting pathological responses.
Studies of the effects of IL-21 on CD4 T-cell differentiation
suggest that it has diverse actions on Th1, Th2, and Th17
lineage development.19,20,22 As we observed no change in
FoxP3, RORgt, or T-bet expression in splenic CD4 T cells post
priming with IL-21 depletion, we infer that endogenous IL-21
does not alter CD4 T-cell differentiation under these condi-
tions. However, we cannot rule an effect on antigen-specific
CD4 T cells, as we did observe a small but significant increase in
IL-17 (but not IFN-g) protein upon specific CD4 T-cell
stimulation in vitro (see Supplementary Figure S3 online).
However, IL-21 depletion reduced the proportion of FoxP3þ
CD4 T cells post RSV challenge, correlated with an increase in
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Figure 4 Interleukin-21 (IL-21) depletion has no effect on FoxP3, RORgt (related orphan receptor-gt), and T-bet expression by splenic CD4 T cells
after priming with recombinant vaccinia virus. Mice were immunized as described in Figure 2. Fourteen days post priming, spleens were harvested.
CD4 T cells were stained for (a) FoxP3, (b) RORgt, or (c) T-bet according to the manufacturer’s instructions. The percentage of CD4 T cells expressing
each transcription factor was determined by flow cytometry and is shown in each dotplot. Grouped data for (d) percentage and (e) total number are
also shown. The graph is representative of two independent experiments of five mice per group. Con, control; Dep, depleted.
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disease severity. As this change was not evident in splenic CD4
T cells (Figure 4a), we conclude that the effects are local and
specific. Therefore, IL-21 not only limits CD4 T-cell
differentiation into pro-inflammatory lineages, but also aids
in the development of regulatory T-cell populations to reduce
pathological responses.
The consequences of the increased pro-inflammatory
potential (and reduced regulatory activity) of these CD4 T
cells are evident after RSV challenge. Weight loss is a reliable
marker of pathology in this model, and the magnitude and
kinetic of weight loss in depleted mice is greater and more
prolonged than controls. The magnitude of weight loss
positively correlates with the degree of cellular recruitment
into the pulmonary compartment. In this study, increases in
CD4 T cells and neutrophils were greatest, followed by CD8 T
cells and NK cells, and finally DCs. As priming activates CD4 T
cells, it is not surprising that (upon recall) their numbers would
increase greatly in the event of increased activation and
expansion caused by a lack of immunoregulatory IL-21. By
contrast, the threefold increase in neutrophilia likely reflects an
increase in chemokine levels (e.g., CXCL1) caused by a more
pro-inflammatory environment. A similar mechanism may be
responsible for the increase in NK cell numbers. CD8 T cells
respond to RSV challenge in an antigen-specific manner, but it
is likely that increased chemokine levels and increased number
of CD4 T cells also help contribute to their increased
recruitment. Nevertheless, an effect of increased DC activation
and recruitment cannot be ruled out as their recruitment
increased threefold in the airway at the peak of pathology, Thus,
it is likely that increased DC recruitment to the airway will
result in increased T-cell activity and cytokine production. IL-
21 reduces MHCII expression on DC, thereby reducing their
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ability to activate CD4 T cells.36 This is supported by DC/CD4
T-cell co-culture, demonstrating thatCD4Tcells fromdepleted
mice produced more cytokine than control cells. The increase
in cytokine production in a subset-independentmanner further
suggests that IL-21 is an anti-inflammatory cytokine and not
subset-biasing. Despite this, no increase of IL-4 was observed in
the airway of depleted mice. This indicates that CD4 T-cell
activation alone does not determine the IL-4 level in the airway,
and that other factors in the environment also contribute. This
may include IFN-g-producing NK cells and CD8 T cells that
would reduce IL-4 and Th2 cytokine secretion, as was observed
in the adoptive transfer experiments. B cells may also be an IL-4
source,37 and their reduction both in this study and in previous
RSV disease studies with strong Th1 cytokine profiles also
indicates them as a source.38
Our data indicate an increase in Th1/Th17 pathological
responses in depleted mice. The increase in IL-10 may reflect
self-regulation by activated T cells, the importance of which has
been highlighted in RSV disease recently.39 The increase in
IL-10 was not associated with increased FoxP3 cell numbers,
which was actually reduced at this time. The increase in lung
CD4 T cells from depleted mice expressing T-bet, RORgt, and
producing IFN-g and IL-17 correlates with the increased
pathology, and cellsmaking thesemediatorsmay be pathogenic
in RSV disease.7 Indeed, CD4 T-cell transfer into naive
recipient mice failed to protect against pathology upon viral
challenge. This failure was associatedwith increasedCD4T-cell
recruitment and increased IFN-g production, similar to the
phenotype observed during primary infection and in the recall
response of primed mice.
Viral clearance is associated with strong cellular immune
responses; however, in this study, we observed a compromised
anti-viral response. This is likely due to the reduction in anti-
viral serum antibody levels, indicative of reduced B-cell activity.
The reduced B-cell recruitment to the airway supports this. The
reduction in viral replication during primary RSV infection and
adoptive transfers is likely due to enhanced lymphocytosis as no
virus-specific antibody is present at this time. Several studies
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have demonstrated a crucial role for IL-21 on both B-cell
activation40 and cells crucial for their activation (e.g., follicular
T helper (Tfh) cells10,41). Early studies demonstrated that IL-21
was crucial for development of antibody-secreting plasma
cells42 and suggest a crucial role for Tfh-derived IL-21 in
antibody production.43 More recent studies show that IL-21
enhances Bcl-6-mediated Tfh-cell development41,44 and has a
critical role in germinal center formation.45,46 Our present
studies show that IL-21 is crucial for optimal antibody
production and that its depletion is detrimental to short-
and long-term protection against viral challenge.
Our studies contrast with a recent report of studies of
pneumovirus of mice (PVM).47 Although PVM and RSV are
similar virologically, PVM induces much more severe disease.
The studies of PVM show that IL-21RKOmice exhibit reduced
disease, cell recruitment, and chemokine/cytokine production;
moreover, mice that constitutively overexpress IL-21 suffer
enhanced disease, with increased recruitment and boosted
chemokine/cytokine production. These studieswere inC57Bl/6
mice rather than BALB/c, and genetic background is known to
be important in many immunological responses. In addition,
the effects of transient mediator depletion during priming are
likely to differ from the effects of life-long genetic deletion, in
which compensatory mechanisms occur.
In conclusion, our findings show that IL-21 has a key role in
limiting the magnitude and regulating the phenotype of virus-
specific CD4 T- and B-cell responses and in anti-viral
immunity in RSV disease. These new insights extend our
understanding of the role of IL-21, which has not previously
been shown to be involved in defense against respiratory
infection. Together with previous studies, our findings high-
light the inherent complexity of IL-21’s functions in respiratory
disease. Moreover, given the genetic heterogeneity of the
human population, further research is warranted to fully
understand the immune function of IL-21 in the respiratory
tract. Based on our findings, we speculate that IL-21 has
therapeutic potential, and co-administration with vaccine
antigens might be particularly effective at inducing protective
immune responses in infancy, when IL-21 responses are
impaired.29
METHODS
Virus and mice. HEp-2-cell-grown plaque-purified A2 strain of RSV
was snap frozen and assayed for infectivity.38 rVV-G (a kind gift ofGail
Wertz, USA) was stored at  801C. All virus preparations were free of
mycoplasma (Gen-Probe, San Diego, CA).
Eight-week-old female BALB/c mice were purchased from Harlan
Olac (Bicester, UK) and kept in specific pathogen-free conditions. All
protocols used in this study were reviewed and approved by ethics,
safety, and regulatory committees.
Mouse infection and treatment. For skin infection, rumps were
shaved, decornified, and infected with rVV-G (10 ml, 106 pfu).38 Some
mice were treated (IP) with 0.5mg anti-IL-21 polyclonal (a kind gift of
Kresten Skak from Novo Nordisk, Denmark) or isotype control
antibody in 0.5ml phosphate-buffered saline (PBS), 1 d before and 2 d
after immunization. For challenge, mice were anesthetized and
infected intranasally with 100 ml (5 105 pfu) of RSV. Mice were
weighed daily thereafter.
The in vivo neutralizing activity of the anti-IL-21 polyclonal
antibodywas confirmed before use. First, wemeasured total serum IgG
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Figure 7 Interleukin-21 (IL-21) depletion increases cytokine production by antigen-specific CD4 T cells. Mice were immunized and challenged as
described in Figure 2 (‘‘ ’’: Isotype control, ‘‘þ ’’ anti-IL-21). Five days post challenge, lungs were harvested. CD4 T cells were sorted by
magnetic activation cell sorter and dendritic cells (DCs) sorted by fluorescent-activated cell sorter. DCs (4104 cells per well) were pulsed with specific
(G184-198; p31) peptide or control (G64-78; p11) peptide (10 mgml1) for 1 h before co-culture with CD4 T cells (4 105 cells per well). Cells
were incubated for 72 h, the supernatants were harvested, and (a) interferon (IFN)-g, (b) IL-10, (c) IL-21, (d) IL-4, and (e) IL-17 levelswere determined by
sandwich enzyme-linked immunosorbent assay. The graphs are representative of three independent experiments of fivemice per group. Student’s t-test
result; *Po0.05, ***Po0.001.
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by ELISA in mice treated on d0, 2, 4, and 6 with vehicle or rmIL-21
(10 ng per dose; intranasally). rmIL-21 significantly increased total
serum IgG levels, and this was ablated by treatment on d( 1) and
d(þ 2) with anti-IL-21 antibody (0.5mg; IP) but not control antibody
(see Supplementary Figure S5a online).
We also determined the time after administration that anti-IL-21
antibody remained effective. rmIL-21 was administered as previously
described, anti-IL-21 (or control) antibody given on d0 (0.5mg; IP),
and total serum antibody levels were determined on d0, 3, and 6. We
found that anti-IL-21 antibody reduced rmIL-21-mediated increases
in total serum IgG on d3, but by d6 antibody levels had returned to d0
levels (see Supplementary Figure S5b online). This confirmed that the
anti-IL-21 antibody was effective for up to 6 d in vivo.
Cell recovery. After killing by IP injection of 3mg of pentobarbital,
BAL fluid, lung tissue, spleen, and serumwere harvested.38 In brief, the
lungs were inflated twice with 1ml of 12mM lidocaine in Earle’s
Balanced Salt Solution and kept on ice. The BAL fluid was centrifuged,
the supernatant removed, and stored at  801C. Pelleted cells were
resuspended inRPMIwith 10% fetal calf serum, 2mMml 1 glutamine,
50 Uml 1 penicillin, and 50mgml 1 streptomycin (‘‘R10F’’). The
cell suspension was passed through a 100-mm filter (Sartorius, Epsom,
UK) and red blood cells lysed with ACK (ammonium chloride-
potassium) buffer. The cells were washed, resuspended in R10F, and
live cells counted using trypan blue.
Quantification of viral replication and gene expression. Total RNA
was extracted and stored in cell lysis and RNA stabilisation RLT buffer
(Qiagen, Crawley, UK). In all, 1 mg total RNA was used to synthesize
cDNAusing randomhexanucleotides in 20 ml. Viral L gene copieswere
measured against standard plasmids (107–101 copies) and anon-template
controls. Also, 100ng cDNA was used per reaction with forward primer
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Figure 8 Interleukin-21 (IL-21) depletion at priming increases interferon (IFN)-g and granzyme B production by splenic CD4 T cells 28 days post
respiratory syncytial virus challenge. Mice were treated as in Figure 2. Twenty-eight days post challenge, spleen cells from both the groups
plus naivemicewere harvested and processed. Spleen cells (2106cells per well) were stimulatedwithmedia, specificG peptide (10mgml 1), or aCD3/
28-expressing beads (50 ml per well) for 72 h. The supernatants were harvested, and (a) IFN-g, (b) IL-4, (c) IL-10, (d) IL-17, (e) granzyme B, and
(f) IL-21 levels were determined by sandwich enzyme-linked immunosorbent assay. The graphs are representative of two independent experiments of
five mice per group. Student’s t-test result; **Po0.01, ***Po0.001.
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(900nM), reverse primer (300nM), and probe (100nM) in 20ml total
volume, using1 cycle of 50 1Cfor2min, 1 cycle of 95 1Cfor10min, 1 cycle
of 95 1C for 15 s, and 1 cycle of 60 1C for 60 s on a ABI 7500 Taqman
Cycler (Applied Biosystems, Warrington, UK). The final two stages are
repeated 45 times in sequence. For gene expression, 100ng cDNA was
used per reaction with specific primer/probe sets and mastermix from
Applied Biosystems (used according to the manufacturer’s instructions).
Total volume and reaction set up was used as for viral L gene analysis
above.Gene expressionwasmeasured as anRQvalue (2DDCt) calculated
using Sequence Detection software v1.4 (Applied Biosystems).
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Figure 9 Interleukin-21 (IL-21) depletion at priming significantly alters the number FoxP3þ , RORgtþ (related orphan receptor-gtþ ), and T-betþ CD4T
cells 28 days post respiratory syncytial virus challenge. Mice were treated as in Figure 2. Twenty-eight days post challenge, spleen cells from
both the groups plus naive mice were harvested and processed. CD4 T cells were stained for (a) FoxP3, (b) RORgt, or (c) T-bet according to the
manufacturer’s instructions. The percentage of CD4 T cells expressing each transcription factor was determined by flow cytometry and is shown
in each dotplot. Grouped data for (d) percentage and (e) total number are also shown. The graph is representative of two independent experiments of five
mice per group. Student’s t-test result; **Po0.01, ***Po0.001.
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Staining and flow cytometric analysis of surface and intracellular
antigens. Cellular phenotyping was performed on BAL, lung, and
spleen cells by flow cytometry as described.38 Briefly, cells were
transferred into 96-well, v-bottomed plates and washed in FACS
(fluorescent-activated cell sorter) staining buffer (PBS/bovine serum
albumin (1%w/v)/NaN3 (0.1%w/v)). Fcg receptors were blocked using
aCD16/32 antibodies, and cells were stained using antibodies against
multiple cell markers. All antibodies were purchased from Biolegend
(London, UK) unless otherwise stated and used at pre-optimized
concentrations. After staining (except for transcription factor expres-
sion, see below), cells were washed in PBS and fixed using paraf-
ormaldehyde (4% v/v) for 20min. Cells were washed and resuspended
in FACS staining buffer and taken for analysis. At least 40 103 cells from
each sample were collected on a Dako Cyan flow cytometer (Ely, UK).
Analysis was performed using Winlist6.0 (Verity, Topsham, ME).
For transcription factor expression, cells were washed in PBS and
fixed and permeabilized using a solution containing paraformalde-
hyde/saponin (eBioscience, Hatfield, UK) overnight at 4 1C. Cells were
then washed in permeablisation buffer (eBioscience) and incubated in
the same buffer (50 ml per well) for 15min. Cells were then stained for
FoxP3, RORgt, or T-bet (1:200 dilution; eBioscience) by adding
permeablisation buffer (50 ml per well) containing relevant antibodies
and incubated for 45min at 4 1C. Cells were washed in permeabilisa-
tion buffer and closed by washing with FACS buffer. Cells were
resuspended in FACS staining buffer and taken for analysis. At least
100 103 cells from each sample were collected on a Dako Cyan flow
cytometer. Analysis was performed using Winlist6.0 (Verity).
In vitro cytokine production by lung or spleen CD4 T cells. Lungs
were harvested and processed as described above. Cells were counted
using trypan blue exclusion assay, set up in 48-well plates (2 106 per
well), and stimulatedwithmedia, RSV (multiplicity of infection 2.0), or
aCD3/aCD28-coated beads (Invitrogen, Paisley, UK; pre-titrated to
10 ml stock per 106 cells) at 37 1C/5% CO2 overnight. Next day,
supernatants were harvested and stored at  80 1C before analysis of
cytokine levels by ELISA. The cells were washed in FACS staining
buffer, and capture reagents for IFN-g, IL-4, IL-10, and IL-17 (Miltenyi
Biotec Cytokine Secretion assay (Bisley, UK); 10 ml per 106 cells; diluted
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Figure 10 Adoptive transfer of CD4 T cells from interleukin-21 (IL-21)-depleted mice exacerbates pathology in recipient mice upon respiratory
syncytial virus (RSV) challenge.Micewere treated as in Figure 2. Twenty-eight days post challenge, splenicCD4Tcells wereMACS (magnetic activation
cell sorter)-sorted and 2 106 cells per mouse were transferred (intraperitoneally) into naive recipients 1 day before RSV infection. Naive T cells
were sorted and transferred into a third group as a control. (a) Weights were measured daily for 14 days. Seven days post challenge, bronchoalveolar
lavage (BAL) fluid and lungs were harvested. The number of FoxP3þ , RORgtþ (related orphan receptor-gtþ ), and T-betþ CD4 T cells in (b) BAL
and (c) lungwere determined by flow cytometry. Recruitment andactivity of (d) CD4Tcells, (e) CD8Tcells, and (f) natural killer (NK) cells to theBALwere
determined by flow cytometry using specific markers. (g) Interferon (IFN)-g, (h) IL-4, and (i) IL-17 levels in BAL fluid were determined by
sandwich enzyme-linked immunosorbent assay. The graphs are representative of three independent experiments of five mice per group. Analysis of
variance (Tukey’s post test) result; *Po0.05, **Po0.01, ***Po0.001. ICOS, inducible costimulatory molecule.
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in cold RPMI) were added to eachwell. Cells were incubated at 4 1C for
15min before addition of 1ml warm media and incubation at 37 1C/
5% CO2 for 1 h to allow cytokine release from cells. Cells were then
washed in FACS staining buffer and stained with detection reagents
(Miltenyi Biotec Cytokine Secretion assay; 10 ml per 106 cells; diluted in
cold FACS staining buffer) for IFN-g-phycoerythrin, IL-4-phycoer-
ythrin, IL-10-allophycocyanin, and IL-17-allophycocyanin. aTCRb-
QR and aCD4-PacBlue or aCD8-PacBlue antibodies were also added
at pre-optimized concentrations to identify CD4 or CD8 T cells. Cells
were then washed in FACS staining buffer before analysis. At least
100 103 cells from each sample were collected on a Dako Cyan flow
cytometer. Analysis was performed using Winlist6.0 (Verity).
Spleen cells were harvested and processed as lung cells. Cells were
counted using trypan blue exclusion assay, set up in 48-well plates
(2 106 per well), and stimulated with media, specific G peptide
(G184-198; 10mgml 1), or aCD3/aCD28-coated beads (Invitrogen;
pre-titrated to 10 ml stock per 106 cells) at 37 1C/5% CO2 for 72 h.
Supernatants were harvested and stored at  80 1C before analysis of
cytokine levels by ELISA.
In vitro cytokine production from sorted DCs andCD4 T cells. Lung
cells from control or IL-21-depleted mice were harvested and pro-
cessed as described above. CD4 T cells from both the groups were
MACS-sorted using a positive isolation kit (Miltenyi Biotech, Bisley,
UK). DCs were FACS-sorted from the remaining cells by staining
using aCD11c-FITC and aCD11b-phycoerythrin antibodies and
collected positively stained cells on a FACS Diva sorter. DC purity of
493% was obtained. Collected DCs were washed, counted, set up at
4 104 per well, and pulsed with a non-specific RSV G-negative
control peptide (p11: G64-78) or antigen-specific peptide (p31: G184-
198; 10 mgml 1). Sorted CD4 T cells (4 105 cells per well) were
added and cultured in 200 ml R10F medium in 96-well, round-bot-
tomed plates. After 72 h, the supernatants were harvested and stored at
 80 1C for cytokine analysis later. IFN-g, IL-4, IL-10, IL-17, and IL-21
were quantified as described below.
Cytokine ELISA. Cytokine levels were quantified using paired
antibodies from R&D Systems (Abingdon, UK; following the man-
ufacturer’s instructions) unless otherwise stated. In brief, microtiter
plates were coated with 100ml (1:200 dilution) of capture antibody
overnight at 4 1C.After threewasheswith PBS containing 0.5%Tween-
20, plates were blocked with 200ml of PBS-1% bovine serum albumin
and left for 2 h at room temperature. Samples and standards (diluted in
PBS with 1% bovine serum albumin and 0.05% Tween 20) were
incubated overnight at 4 1C. After four washes, bound cytokine was
detected using biotinylated antibodies, then avidin–horseradish
peroxidase, followed by O-phenylenediamine dihydrochloride
(OPD), read at 490 nm. Standard curves were used to calculate sample
concentrations.
RSV-specific antibody ELISA. RSV-specific IgA, IgE, IgG1, and
IgG2awas detected by coating 96-well plateswithRSV antigen orHep2
control materials, incubating overnight at 4 1C with different serum
dilutions (1:2 dilutions starting at 1:100), and detecting Ig with biotin-
conjugated anti-mouse Ig antibodies (BectonDickinson, Oxford, UK),
avidin–horseradish peroxidase, and OPD as described above. Results
were expressed as optical density values.
MACS sorting and adoptive transfer of splenic CD4 T cells. Mice
were immunized, challenged, and depleted of IL-21 (or not) as
described above. The mice were left for 28 d, and the spleens were
harvested. CD4 T cells were purified using a positive isolation kit
(Miltenyi Biotech; according to the manufacturer’s instructions). CD4
T-cell purity of490% was obtained. 5 106 cells were transferred IP
into each recipient mouse 24 h before RSV challenge. Mice were
monitored daily and BAL and lungs harvested 7 d PC.
Data analysis. A Student’s t-test was used to analyze differences
between the two groups. One-way analysis of variance (ANOVA) was
used to analyze differences between more than two groups and
significance was assumed at Po0.05. A Tukey’s post test was used to
identify differences between specific groups, with a significance
threshold of Po0.05.
SUPPLEMENTARYMATERIAL is linked to the online version of the paper
at http://www.nature.com/mi
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